Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « MeshFr.i » - entrée « Pronostic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pronase < Pronostic < Propan-2-ol  Facettes :

List of bibliographic references indexed by Pronostic

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000185 (2019) Fereshteh Shojaei ; Farshad Yazdani-Nafchi ; Mehdi Banitalebi-Dehkordi ; Mohammad Chehelgerdi ; Milad Khorramian-Ghahfarokhi [Iran]Trace of survivin in cancer.
000350 (2019) Ji-Chang Wang [République populaire de Chine] ; Guang-Yue Li [République populaire de Chine] ; Bo Wang [République populaire de Chine] ; Su-Xia Han [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Yi-Na Jiang [République populaire de Chine] ; Yan-Wei Shen [République populaire de Chine] ; Can Zhou [République populaire de Chine] ; Jun Feng [République populaire de Chine] ; Shao-Ying Lu [République populaire de Chine] ; Jian-Lin Liu [République populaire de Chine] ; Mao-De Wang [République populaire de Chine] ; Pei-Jun Liu [République populaire de Chine]Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.
000373 (2019) Patrizia Mondello [Italie] ; Cristian Di Mirto [Italie] ; Salvatore Cuzzocrea [Italie] ; Carmela Arrigo [Italie] ; Michael Mian [Italie] ; Vincenzo Pitini [Italie]Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms.
000484 (2019) Anbok Lee [Corée du Sud] ; Sunmi Jo [Corée du Sud] ; Changhu Lee [Corée du Sud] ; Hyun-Hee Shin [Corée du Sud] ; Tae Hyun Kim [Corée du Sud] ; Ki Jung Ahn [Corée du Sud] ; Sung-Kwang Park [Corée du Sud] ; Heunglae Cho [Corée du Sud] ; Hye-Kyoung Yoon [Corée du Sud] ; Woo Gyeong Kim [Corée du Sud] ; Jiyoung Park [Corée du Sud] ; Yunseon Choi [Corée du Sud]Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
000516 (2019) Iman Hamed Bassyouni [Égypte] ; Wafaa Hob Sharkawy Mohammed [Égypte] ; Fatma M. Taha [Égypte] ; Rasha M. El Refai [Égypte]Clinical significance of CCN2/connective tissue growth factor in Behçet's disease patients.
000525 (2019) Che-Mai Chang [Taïwan] ; Yu-Wen Hsu [Taïwan] ; Henry Sung-Ching Wong [Taïwan] ; James Cheng-Chung Wei [Taïwan] ; Xiao Liu [États-Unis] ; Hsien-Tzung Liao [Taïwan] ; Wei-Chiao Chang [Taïwan]Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies.
000662 (2018) Patrik Rorsman [Royaume-Uni, Suède] ; Mark O. Huising [États-Unis]The somatostatin-secreting pancreatic δ-cell in health and disease.
000828 (2018) Benjamin Lockshin [États-Unis] ; Yevgeniy Balagula [États-Unis] ; Joseph F. Merola [États-Unis]Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis.
000845 (2018) Stephen A. Williams ; Ashwin C. Murthy ; Robert K. Delisle ; Craig Hyde ; Anders Malarstig ; Rachel Ostroff ; Sophie J. Weiss ; Mark R. Segal ; Peter Ganz [États-Unis]Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
000978 (2018) Aideen M. Campbell [Royaume-Uni] ; Melanie Morris [Royaume-Uni] ; Rebecca Gallagher [Royaume-Uni] ; Ruth Boyd [Royaume-Uni] ; Hazel Carson [Royaume-Uni] ; D Paul Harkin [Royaume-Uni] ; Ewa Wielogorska [Royaume-Uni] ; Christopher Elliott [Royaume-Uni] ; Kienan I. Savage [Royaume-Uni] ; Stuart A. Mcintosh [Royaume-Uni]Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.
000A95 (2017) Rubén A. Bartolomé [Espagne] ; Sofía Torres [Espagne] ; Soledad Isern De Val [Espagne] ; Beatriz Escudero-Paniagua [Espagne] ; Eva Calvi O [Espagne] ; Joaquín Teixid [Espagne] ; J Ignacio Casal [Espagne]VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
000B64 (2017) Claudio Isella [Italie] ; Francesco Brundu [Italie] ; Sara E. Bellomo [Italie] ; Francesco Galimi [Italie] ; Eugenia Zanella [Italie] ; Roberta Porporato [Italie] ; Consalvo Petti [Italie] ; Alessandro Fiori [Italie] ; Francesca Orzan [Italie] ; Rebecca Senetta [Italie] ; Carla Boccaccio [Italie] ; Elisa Ficarra [Italie] ; Luigi Marchionni [États-Unis] ; Livio Trusolino [Italie] ; Enzo Medico [Italie] ; Andrea Bertotti [Italie]Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
000C17 (2017) Emily B. Schroeder [États-Unis] ; Stan Xu [États-Unis] ; Glenn K. Goodrich [États-Unis] ; Gregory A. Nichols [États-Unis] ; Patrick J. O'Connor [États-Unis] ; John F. Steiner [États-Unis]Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: Development and external validation of a prediction model.
000C78 (2017) Dong Ren [République populaire de Chine] ; Bihua Lin [République populaire de Chine] ; Xin Zhang [République populaire de Chine] ; Yao Peng [République populaire de Chine] ; Ziyu Ye [République populaire de Chine] ; Yan Ma [République populaire de Chine] ; Yangfang Liang [République populaire de Chine] ; Longbin Cao [République populaire de Chine] ; Xiangyong Li [République populaire de Chine] ; Ronggang Li [République populaire de Chine] ; Lixia Sun [République populaire de Chine] ; Qiongru Liu [République populaire de Chine] ; Jinhua Wu [République populaire de Chine] ; Keyuan Zhou [République populaire de Chine] ; Jincheng Zeng [République populaire de Chine]Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
000D30 (2017) Shinro Hata [Japon] ; Takeo Nomura [Japon] ; Kazunori Iwasaki [Japon] ; Ryuta Sato [Japon] ; Mutsushi Yamasaki [Japon] ; Fuminori Sato [Japon] ; Hiromitsu Mimata [Japon]Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
000E50 (2017) Takuya Furuta [Japon] ; Hemragul Sabit [Japon] ; Yu Dong [Japon] ; Katsuyoshi Miyashita [Japon] ; Masashi Kinoshita [Japon] ; Naoyuki Uchiyama [Japon] ; Yasuhiko Hayashi [Japon] ; Yutaka Hayashi [Japon] ; Toshinari Minamoto [Japon] ; Mitsutoshi Nakada [Japon]Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
000F54 (2016) Ayako Nakajima[Cardiovascular diseases in rheumatoid arthritis].
000F78 (2016) Chia-Lin Liu [Taïwan] ; Su-Feng Chen [Taïwan] ; Min-Zu Wu [États-Unis] ; Shu-Wen Jao [Taïwan] ; Yaoh-Shiang Lin [Taïwan] ; Chin-Yuh Yang [Taïwan] ; Tsai-Yu Lee [Taïwan] ; Lian-Wu Wen [Taïwan] ; Guo-Lun Lan [Taïwan] ; Shin Nieh [Taïwan]The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
000F94 (2016) Sixuan Qian [République populaire de Chine] ; Jianyong Li [République populaire de Chine] ; Ming Hong [République populaire de Chine] ; Yu Zhu [République populaire de Chine] ; Huihui Zhao [République populaire de Chine] ; Yue Xie [République populaire de Chine] ; Jiayu Huang [République populaire de Chine] ; Yun Lian [République populaire de Chine] ; Yanru Li [République populaire de Chine] ; Shuai Wang [République populaire de Chine] ; Jianping Mao [République populaire de Chine] ; Yaoyu Chen [République populaire de Chine]TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
001094 (2016) George Papaxoinis [Royaume-Uni] ; Kostas Syrigos [Grèce] ; Muhammad Wasif Saif [États-Unis]New concepts in the treatment strategy of neuroendocrine tumors: the role of biotherapy.
001140 (2016) Fabrizio Cantini [Italie] ; Ennio Lubrano [Italie] ; Antonio Marchesoni [Italie] ; Alessandro Mathieu [Italie] ; Ignazio Olivieri [Italie] ; Carlo Salvarani [Italie] ; Raffaele Scarpa [Italie] ; Antonio Spadaro [Italie]Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Pronostic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Pronostic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Pronostic
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020